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Background:Many of the factors that are known to alter left atrial (LA) contractility are present in patients with
ischemic cardiomyopathy (ICM). Nevertheless, preservation of LA contractile function in this group of patients
was reported in previous studies. The aim of this study was to assess the changes in LA size, geometry and con-
tractile function in ICM.
Methods and results: 60 subjects (age: 49 ± 12 years, 53% males) in sinus rhythm undergoing coronary angiog-
raphy (CA), were enrolled in this study; 15 subjects as a control group, 30 patients with reduced ejection fraction
(EF) and signiﬁcant coronary artery disease; as the ICM group, and 15 with reduced EF and normal CA; as the di-
lated cardiomyopathy (DCM) group.
LA dimensions, volume, active emptying fraction (ACTEF) and eccentricity index (LAEi) as well as late diastolic
velocities of the mitral annulus (a′) and LA free wall (A3) were measured.
Compared with the control group, ICM patients had larger LA volume and reduced ACTEF, a′ and A3, with no sig-
niﬁcant difference between patients with ICM and DCM in any of these parameters. LA eccentricity was, non-
signiﬁcantly, higher in both cardiomyopathy groups than in the control group.
Conclusions: Patientswith ICMhave increased LA volume and reduced LA contractile function in comparisonwith
normal controls. LA enlargement, LA contractile dysfunction and LA geometric changes in ICM are similar to that
occurring in DCM. LA size, contractile function and eccentricity may not be reliable in differentiating ischemic
from idiopathic dilated cardiomyopathy.© 2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Left atrial (LA) size and function are powerful predictors of outcome
in heart failure (HF) patients with predominantly impaired systolic
function, adding important clinical information, independent of any of
its determinants [1–3]. In addition to its prognostic value, LA size and
function have been linked to exercise capacity and hospitalizations in
patients with HF [3,4]. These ﬁndings have drawn attention to the im-
portance of LA size and function in patients with systolic heart failure.
Histological evidence of a high degree of ﬁbrosis in the LAwas found
in patientswith idiopathic dilated cardiomyopathy (DCM) but not in pa-
tients with old myocardial infarction despite similar degrees of left ven-
tricular (LV) dysfunction. These ﬁndings suggested that atrial ﬁbrosis in
these patients may not have been related to mechanical overload of the
left atrium but rather to LA involvement in the myopathic process [5].
These ﬁndings were further emphasized in a number of observationald, Al-Velal, Benha, Al-Qalyubia
, dr_m.abdelghani@yahoo.com
eliability and freedom from bias
en access article under the CC BY-NCstudies that reported LA contractile dysfunction in DCM and preserva-
tion in ischemic cardiomyopathy (ICM) [4,6,7].
LA contractile dysfunction was, however, demonstrable in patients
with coronary artery disease (CAD) even when the LV systolic function
was preserved and LA was not enlarged [8].
With the progression of myocardial ischemia, and as the LV systolic
and diastolic functions deteriorate, poor LV-ejection fraction (EF) and
the presence of severe diastolic dysfunction causing a restrictive LV-
ﬁlling pattern (RFP) become the most important determinants of LA
contractile function in CAD patients [9]. LA contractile function is,
thus, expected to be altered in patients with ICM (where LV systolic
function is impaired and severe diastolic dysfunction {RFP} is common).
We conducted this study primarily to assess LA size, geometry and con-
tractile function in patients with ICM.
2. Methods
The study protocol conforms to the ethical guidelines of the 1975
Declaration of Helsinki and was approved by the institutional review
board. Sixty patients referred to Bab El-Sha'rya University Hospital for
diagnostic coronary angiography (CA) and transthoracic echocardiogra-
phy between May 2011 and June 2012, were enrolled. All patients pro-
vided written informed consent.-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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deﬁned as a reduced EF (b45%) and CA showing signiﬁcant CAD propor-
tionate with the degree of LV dysfunction (multivessel, left main or
proximal left anterior descending artery stenosis), previous myocardial
infarction or coronary revascularization [10]. DCM patients had an
EF b 45% and normal CA.
In addition, 15 control subjects with normal EF, normal diastolic
function and normal CA were included.
The exclusion criteria were: 1) atrial ﬁbrillation; 2) conduction de-
fects; 3) signiﬁcant organicmitral or aortic valve disease and 4) a recent
myocardial infarction (b1 month).
2.1. Echocardiography
All patientswere imaged in the left lateral position using an EsaoteMy
Lab5Goldultrasound system. Left atrialmaximumvolume (LAVmax)was
measured at LV end systole, LAminimal volume (LA Vmin) at LV end dias-
tole and LA volume at the onset of atrial contraction (Vp) at the onset of
electrocardiographic P wave from the apical four-chamber and apical
two-chamber views using the biplane area–length method (Fig. 1) [11].
LA active emptying fraction ACTEF equals the difference between Vp
and Vmin, divided by Vp i.e. ACTEF = (Vp-Vmin)/Vp [12,13].
LA antero-posterior dimension (D1) wasmeasured at end systole in
the parasternal long axis view from the trailing edge of the posterior
aortic wall to the leading edge of the posterior LA [11]. The superior–
inferior (D2) and medio-lateral dimensions (D3) were measured in
the apical four chamber view at end systole (Fig. 1). We used left atrial
eccentricity index (LAEi = {2 × D2} / {D1+ D3}) to assess the changes
in the LA shape [14].
Tissue Doppler velocities were measured in the apical four-chamber
view at the septal side of themitral annulus andmid-segment of LA free
wall, using pulsed wave tissue Doppler. Peak velocity of septal mitral
annulus at late diastole (a′) [15–17] and atrial contraction peak velocity
at the mid segment of the LA lateral wall (A3) [18,19] were measured
and used as markers of LA contractility.Fig. 1. Left; left atrial volumemeasured using biplane (apical four, upper, and two chamber, low
and medio-lateral (lower) diameters.To measure septal a′, the sample volume was placed on the atrial
side of themitral annulus at the basal inter-atrial septum from the apical
four-chamber view [12]. To measure A3, sample volume of 4 mm was
put at the mid segment of the LA lateral wall in apical four-chamber
view. Special care was taken to place the sample volume away from
the pulmonary vein entrance [18].
Left ventricular end-diastolic and end-systolic dimensions were
measured and fractional shortening was calculated from the
parasternal long axis view. Left ventricular end-diastolic and end-
systolic volumes were measured and EF was calculated from the api-
cal four-chamber and two-chamber views using modiﬁed biplane
Simpson's method [11].
Mitral E-wave and A-wave velocities, E/A ratio, and E-wave deceler-
ation time (DT) were also measured using pulsed wave Doppler with
the sample volume put at the tips of the mitral valve leaﬂets. E-wave
DT was measured as the interval in milliseconds (ms), from the peak
of E-wave to an extrapolation of the deceleration to 0 m/s. Severe dia-
stolic dysfunction/restrictive LV-ﬁlling was deﬁned by the presence of
the following criteria: E/A ratio N 2, DT b 160 ms and E/e′ N 15 [20].
Mitral regurgitation (MR) was semi-quantitatively assessed by color
ﬂow Doppler echocardiography. Four grades of regurgitant jet area
were determined (1 = regurgitant jet area b 1.5 cm2; 2 = regurgitant
jet area 1.5–3 cm2, 3= regurgitant jet area 3–8 cm2 and 4= regurgitant
jet area N 8 cm2) [21].2.2. Statistical analysis
Data are presented as themean value± standard deviation (SD) for
continuous variables and as numbers and frequency percentages for
categorical variables. Comparisons of continuous variables between
groups were made using the unpaired t test, whereas categorical vari-
ables were compared by the Chi-square and Fisher's exact tests.
Correlation between the LA volume and ACTEF was tested by
Pearson's correlation coefﬁcient.er, views) area–lengthmethod. Right; left atrial antero-posterior (upper), superior–inferior
Table 2
Left atrial volume, contractile function and geometry.
ICM (n = 30) DCM (n = 15) Control (n = 15)
LAVmax (ml) 78 ± 25⁎ 85 ± 34 48 ± 13
ACTEF (%) 29 ± 13⁎ 27 ± 10 41 ± 10
Septal a′ (cm/s) 8 ± 2.9⁎ 7.6 ± 2.4 10.7 ± 2.9
LA3 (cm/s) 10.4 ± 5.1⁎ 10.5 ± 4.3 17.3 ± 5.9
LAD1 (cm) 4.1 ± 0.7⁎ 3.9 ± 0.8 3.2 ± 0.4
LAD2 (cm) 5.4 ± 0.9⁎ 5.7 ± 0.6 4.6 ± 1.1
LAD3 (cm) 4.6 ± 0.9 4.6 ± 0.8 4.3 ± 0.7
LAEi 1.26 ± 0.2 1.36 ± 0.1 1.22 ± 0.3
Data are presented as mean ± SD.
LAVmax = left atrial maximum volume, ACTEF = left atrial active emptying fraction,
a′ = mitral annular late diastolic peak velocity, LA3 = left atrial free wall velocity at
atrial contraction, LAD1 = left atrial antero-posterior dimension, LAD2 = left atrial supe-
rior–inferior dimension, LAD3 = left atrialmedio-lateral dimension, LAEi = left atrial ec-
centricity index, ICM = ischemic cardiomyopathy, and DCM = dilated cardiomyopathy.
⁎P b 0.05; ICM vs control.
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tween the groupswith a SD of 10%, atα level of 0.05. A two-tailed prob-
ability (P) value of ≤0.05 was used to deﬁne a signiﬁcant result.
3. Results
3.1. Baseline characteristics
ICM patients were older than patients with DCM and control sub-
jects. The proportion of males was higher in ICM and DCM groups
than in the control group. The prevalence of HTN was similar in the
three groups.
Compared with the control group, patients with ICM and DCM had
signiﬁcantly higher left ventricular end-diastolic dimension (LVEDD),
MR grade and prevalence of severe diastolic dysfunction. LV ejection
fraction (EF), septal mitral annular e′ velocity and E-wave deceleration
time (DT) were signiﬁcantly lower in ICM and DCM groups than in the
control group. Table 1 shows the baseline clinical and echocardiographic
characteristics of the patients and controls.
3.2. LA volume and emptying fraction
LA maximum volume was larger in ICM patients than in controls
(Table 2, P = 0.0001), but there was no signiﬁcant difference between
ICMandDCMgroups (P= 0.41). LA active emptying fractionwas lower
in ICMpatients than in the control group (P= 0.0046), but without sig-
niﬁcant difference between patients with ICM and DCM (P = 0.66).
3.3. Mitral annulus and LA free wall velocities at atrial contraction
(Septal a′ and LA3)
As shown in Table 2, ICM patients had lower septal a′ and A3 than
controls (P = 0.005 and 0.003, respectively), but no signiﬁcant differ-
ence was noted between ICM and DCM patients (P = 0.67 and 0.93,
respectively).
3.4. LA geometry
Left atrial antero-posterior and the superior–inferior dimensionswere
longer in ICMpatients than in the control group (Table 2, P= 0.0001 and
0.016, respectively). However, medio-lateral dimension showed no sig-
niﬁcant difference than in controls (P= 0.25). Similar geometric changes
were noted in DCM patients (P values — ICM vs. DCM — for D1, D2 and
D3 = 0.48, 0.24, 0.9). Compared with the control group, LA geometry
was more elongated in the 2 cardiomyopathy groups, yet such increaseTable 1
Clinical and echocardiographic characteristics.
ICM
(n = 30)
DCM
(n = 15)
Control
(n = 15)
Age (year) 56 ± 8⁎§ 40 ± 10 44 ± 13
Male, n (%) 22 (73)⁎ 7 (47) 3 (20)
Hypertension, n (%) 16 (53) 6 (40) 5 (33)
LVEDD (cm) 6.1 ± 0.8⁎ 6.3 ± 0.9 4.8 ± 0.6
LVEF (%) 34 ± 8⁎ 31 ± 8 62 ± 5
Septal e′ (cm/s) 6.5 ± 3⁎ 5 ± 3 10.6 ± 3
DT (ms) 154 ± 59⁎ 180 ± 70 212 ± 35
Severe diastolic dysfunction, n (%) 11 (35)⁎ 4 (27) 0
MR grade 1.8 ± 1⁎ 1.9 ± 1.5 0.8 ± 0.8
Data are presented as mean ± SD or n (%).
LVEDD = left ventricular end-diastolic dimension, LVEF = left ventricular ejection frac-
tion, e′ = mitral annular early diastolic peak velocity, DT = E-wave deceleration time,
MR = mitral regurgitation, ICM = ischemic cardiomyopathy, and DCM = dilated
cardiomyopathy.
⁎ P b 0.05; ICM vs control.
§ P b 0.05; ICM vs DCM.in LAEi did not reach statistical signiﬁcance even in the more elongated
DCM group (P value for LAEi — DCM vs. control—=0.27).
3.5. Comparison between cardiomyopathy patients with and without
restrictive LV ﬁlling pattern – RFP – (Table 3)
When cardiomyopathy patients – from both ICM and DCM groups –
with RFP (18 patients) were compared with cardiomyopathy patients
with less severe diastolic dysfunction (non-RFP, 27 patients); no signiﬁ-
cant differencewas noted in LVEF orMR (P=0.2 and 0.15, respectively).
However, thosewith RFP had a larger LA Vmax (P= 0.02) and amore de-
pressed LA pump function than non-RFP patients (ACTEF: 25 ± 12 vs
33 ± 13%, P = 0.057; septal a′: 6.4 ± 2.6 vs 9.2 ± 2.1 cm/s, P = 0.001;
A3: 8.1 ± 4 vs 12.4 ± 4.6 cm/s, P = 0.006).
4. Discussion
The present study showed that LA remodeling is frequent in patients
with ICM. ICM patients have a signiﬁcantly enlarged LA and a signiﬁ-
cantly reduced LA contractile function. This conclusion is supported by
the concordance in three indices of LA booster pump function, namely;
LA active emptying fraction, mitral annular and LA freewall velocities at
atrial contraction. On the other hand, LA volume, geometry and atrial
pump function, were not signiﬁcantly different between ICM and DCM
patients.
4.1. LA function in cardiomyopathy with impaired systolic function
Idiopathic dilated cardiomyopathy (DCM) is a diffuse process.
Cardiomyocytes of both ventricles are involved and atrial function is
also decreased. The typical gross pathologic picture is that of 4-chamber
enlargement [22]. Unlike DCM, ischemic heart disease primarily affectsTable 3
Comparison between cardiomyopathy patients with and without RFP.
RFP (n = 18) Non-RFP (n = 27) P value
LVEF (%) 32 ± 9 35 ± 7 0.2
MR grade 2.1 ± 1.2 1.6 ± 1.2 0.15
LAVmax (ml) 89 ± 28 69 ± 24 0.02
ACTEF (%) 25 ± 12 33 ± 13 0.057
Septal a′ (cm/s) 6.4 ± 2.6 9.2 ± 2.1 0.001
LA3 (cm/s) 8.1 ± 4 12.4 ± 4.6 0.006
Data are presented as mean ± SD.
RFP = restrictive ﬁlling pattern, LVEF = left ventricular ejection fraction, MR = mitral
regurgitation, LAVmax = left atrialmaximumvolume, ACTEF = left atrial active emptying
fraction, septal a′ = septal mitral annulus peak velocity at late diastole, and LA3 = left
atrial free wall velocity at atrial contraction.
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Fig. 2.Correlation plot between left atrialmaximumvolume (LAVmax) and left atrial active
emptying fraction (ACTEF) in ischemic cardiomyopathy patients.
Table 4
Frequency of RFP in patients with dilated/ischemic cardiomyopathy in 4 observational
studies.
Number of patients and etiology of
cardiomyopathy included in the study
% of RFP
Rossi et al. [2] 337 (75% ischemic and 25% idiopathic) 22%
Pratali et al. [31] 116 (idiopathic) 32%
Ito et al. [30] 41 (mainly, idiopathic) 32%
Yong et al. [32] 40 (ischemic) 48%
RFP = restrictive ﬁlling pattern of left ventricular ﬁlling.
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DCM was further emphasized in a number of observational studies.
Right ventricular function was signiﬁcantly better in patients with ische-
mic cardiomyopathy as compared to patients with dilated cardiomyopa-
thy in a magnetic resonance study [23].
Likewise, LA contractile function (estimated by active emptying frac-
tion [7] and systolic deformation [4]) was shown to be more depressed
in DCM than in ICM patients. Some authors concluded that LA contrac-
tility is preserved in ICM patients, showing no measurable impairment
compared with normal controls [7].
The current study, however, showed that LA pump function is de-
pressed in patients with ICM. It is likely that increased LA afterload, be-
cause of the elevated LV diastolic pressure [24], plays amajor role in this
process. Studies in both animals and humans have shown that LA size
increases with LA pressure overload, with an associated initial gain in
contractile shortening. However, with progressive dilatation of the LA
which eventually leads to a threshold ﬁber length, atrial shortening
and contractility begin to decline [12].
Impairment of LV diastolic performance starts early in CAD and pro-
gresses as negative LV remodeling ensues [25].
4.2. LA function in ischemic heart disease
Atrial contractile dysfunction appears early in ischemic heart disease
(IHD), irrespective of previousmyocardial infarction, co-existing systol-
ic dysfunction, or severity of diastolic dysfunction [26,9,8]. Yu et al.
found that the peak regional atrial contraction velocities at atrial systole
(VAa)measured atmid-level of the inter-atrial septum and the lateral LA
in the apical four chamber view were drastically reduced in patients
with IHDwhen comparedwith normal controls. Furthermore, each per-
cent increase in ejection fraction correlatedwith an increase in VAa in LA
by 0.06 cm/s, while the occurrence of a restrictive ﬁlling patternwas as-
sociated with a reduction of VAa in LA by 3.17 cm/s. A poor LV-ejection
fraction and the presence of severe diastolic dysfunction (restrictive
LV-ﬁlling pattern) were the most important determinants of LA con-
tractile dysfunction in IHD [9].
Left ventricular diastolic dysfunction precedes systolic wall motion
abnormalities in the ischemic cascade [25]. LA structural and functional
remodeling have been proposed as a barometer of diastolic burden, and
this, at least partially, explains the causal link between IHD and LA dila-
tation and dysfunction.
4.3. LA size and function as markers of LV properties
Left atrial volume, function and geometry have emerged as a com-
prehensive marker of left ventricular properties. LV mass, dimension,systolic and diastolic function were proved to be independent determi-
nants of LA volume [2,27]. LA volume has,also been identiﬁed as amajor
determinant of LA contractile function [27]. In our cohort of ICM
patients, ACTEF was negatively correlated with LA Vmax (Fig. 2,
r = −0.5, P = 0.005).
Patients with impaired LV diastolic performance have increased LA
volumes and decreased LA contractility that parallel the severity of dia-
stolic dysfunction, such that patients with severe diastolic dysfunction
(restrictive LV-ﬁlling pattern) have the largest atrial volumes and the
worst LA booster pump function [28–30].
In our cohort of cardiomyopathy patients, severe diastolic dysfunc-
tion was found in 18/45 patients (40%). This high prevalence of restric-
tive LV-ﬁlling was also noted in other observational studies (Table 4).
The high prevalence of severe diastolic dysfunction and the “elon-
gated” geometry of the left atrium in cardiomyopathy patients sug-
gested a major role of LV ﬁlling pattern on LA properties in this group
of patients [14]. In order to test this assumption, our 45 cardiomyopathy
patients (regardless of etiology) were divided into two groups accord-
ing to the presence or absence of severe diastolic dysfunction (RFP).
Both groups were comparable regarding LV EF and MR grade (Table 3).
Categorizing patients with cardiomyopathy and reduced ejection
fraction according to the severity of diastolic dysfunction, rather than
according to etiology, identiﬁed two subgroupswith signiﬁcantly differ-
ent LA properties, with larger LA size and more depressed contractile
function in those with restrictive LV ﬁlling (Fig. 3).5. Limitations
Small number of patients is a limitation, but the study had adequate
power to detect at least a 15% difference in the primary parameter of in-
terest, ACTEF, between the compared groups. The main ﬁnding of this
study, that could be concluded upon, was that the LA pump function is
signiﬁcantly reduced in ICM patients compared with control subjects.
Nevertheless, larger sample size may detect smaller differences
(b15%) between ICM and DCM groups in LA pump function parameters
and between cardiomyopathy patients and controls in LA eccentricity.
The use of multiple comparisons among several patients' groups is an-
other downside. Given the small sample size, additional studies are rec-
ommended to examine LA contractility, particularly using novel
echocardiographic markers of LA deformation, in a larger population.
Patients with ICM were signiﬁcantly older than the other groups.
However, it has been shown that aging is associated with an increase
in active atrial contraction in response to increased LV stiffness
[12,33]. So, an even worse LA contractility in ICM group is expected if
patients in this group were younger. Male gender was more found in
the two cardiomyopathy groups than in controls. LA size tends to be
larger in men than women, but this difference can be attributed to the
variations in relativeweight and body size [34].When adjusted for atrial
size, there are no sex related differences in LA function [35].
About one third of control subjects were hypertensive. This was in-
evitable in a cohort of patients referred for invasive coronary angiogra-
phy. Most of these patients had a risk proﬁle that justiﬁed invasive
evaluation of their symptoms. However, those with any echocardio-
graphic sign of diastolic or systolic dysfunction were excluded.
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Fig. 3. Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) did not differ signiﬁcantly in left atrial active emptying fraction (LA ACTEF), septal a′ or left atrial late diastolic
velocity (LA A3). On the other hand, cardiomyopathy patientswith restrictiveﬁlling pattern (RFP) had lower indices of LA contractility than thosewithout RFP. *RFP vsNon-RFP; P value for
ACTEF was 0.057. P value for septal a′ and LA A3 was b0.05.
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rate measure of LA size [36].
The study did not investigate the molecular mechanisms that ac-
count for the changes in LA function, and additional research can shed
light on this area.
6. Conclusion
LA is enlarged and its contractility is reduced in patients with ICM.
The geometric and functional changes observed in left atria of patients
with ICM are similar to the changes observed in patients with DCM.
These ﬁndings contrast to previous reports that pointed to LA contrac-
tile function preservation in patients with ICM.
Larger LA with more depressed contractile function may indicate
worse LV diastolic performance in patients with LV systolic dysfunction
rather than indicating a certain etiology of cardiomyopathy.
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